The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data


Variant: NM_001110792.2(MECP2):c.553C>A (p.Pro185Thr)

CA415173958

804125 (ClinVar)

Gene: MECP2
Condition: Rett syndrome
Inheritance Mode: X-linked inheritance
UUID: 620fe876-df5e-4691-833d-2490e0485e3e
Approved on: 2024-08-30
Published on: 2024-12-23

HGVS expressions

NM_001110792.2:c.553C>A
NM_001110792.2(MECP2):c.553C>A (p.Pro185Thr)
NC_000023.11:g.154031311G>T
CM000685.2:g.154031311G>T
NC_000023.10:g.153296762G>T
CM000685.1:g.153296762G>T
NC_000023.9:g.152949956G>T
NG_007107.2:g.110817C>A
NG_007107.3:g.110793C>A
ENST00000303391.11:c.517C>A
ENST00000453960.7:c.553C>A
ENST00000637917.1:c.65+85C>A
ENST00000303391.10:c.517C>A
ENST00000407218.5:c.469-25C>A
ENST00000453960.6:c.553C>A
ENST00000486506.5:n.2865C>A
ENST00000611468.1:c.503C>A
ENST00000619732.4:c.517C>A
ENST00000622433.4:c.505C>A
ENST00000628176.2:c.433-25C>A
NM_001110792.1:c.553C>A
NM_001316337.1:c.238C>A
NM_004992.3:c.517C>A
NM_001316337.2:c.238C>A
NM_001369391.2:c.238C>A
NM_001369392.2:c.238C>A
NM_001369393.2:c.238C>A
NM_001369394.1:c.238C>A
NM_001369394.2:c.238C>A
NM_001386137.1:c.-128-25C>A
NM_001386138.1:c.-128-25C>A
NM_001386139.1:c.-128-25C>A
NM_004992.4:c.517C>A
More

Uncertain Significance

Met criteria codes 1
BS2_Supporting
Not Met criteria codes 6
PM1 PM5 PM2 BS1 PS1 BA1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Rett and Angelman-like Disorders Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for MECP2 Version 3.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The highest population minor allele frequency of the p.Pro173Thr variant in MECP2 (NM_004992.4) in gnomAD v4.1 is 0.000002233 in European (non-Finnish) population (not sufficient to meet BS1 criteria). The p.Pro173Thr variant is observed in at least 1 unaffected individual (internal database - GeneDx) (BS2_Supporting). The p.Pro173Thr variant is not currently published and is not present in additional databases (internal and publicly available), therefore, no additional criteria are applicable at this time. In summary, the p.Pro173Thr variant in MECP2 is classified as a variant of uncertain significance based on the ACMG/AMP criteria (BS2_Supporting). (MECP2 specification v3.0.0, curation approved on 8/30/2024)
Met criteria codes
BS2_Supporting
The p.Pro173Thr variant is observed in at least 1 unaffected individual (internal database - GeneDx) (BS2_Supporting).
Not Met criteria codes
PM1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM2
The highest population minor allele frequency of the p.Pro173Thr variant in MECP2 (NM_004992.4) in gnomAD v4.1 is 0.000002233 in European (non-Finnish) population (not sufficient to meet PM2 criteria).
BS1
The highest population minor allele frequency of the p.Pro173Thr variant in MECP2 (NM_004992.4) in gnomAD v4.1 is 0.000002233 in European (non-Finnish) population (not sufficient to meet BS1 criteria).
PS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BA1
The highest population minor allele frequency of the p.Pro173Thr variant in MECP2 (NM_004992.4) in gnomAD v4.1 is 0.000002233 in European (non-Finnish) population (not sufficient to meet BA1 criteria).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.